为免疫议程2030建模疫苗接种的影响:2021至2030年194个国家针对14种病原体疫苗接种所避免的死亡
BACKGROUND: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade.…
核心结论
- 全球分析结果表明,若到2030年实现免疫议程2030目标,可实现的死亡减少潜力巨大。
- 疫苗可预防疾病导致的死亡对非洲区域中低收入国家影响尤为严重。
研究设计与样本
- 使用人口学模型确定与疫苗覆盖率相关的年度年龄别死亡估计。
- 对10种病原体,利用疫苗影响模型联盟(VIMC)18个建模组覆盖110个国家的数据,推导国家、年龄和病原体别相对死亡风险,并用逻辑回归外推至未建模国家。
- 对4种病原体(白喉、破伤风、百日咳和结核病),使用2019年全球疾病负担研究和现有疫苗效力文献的估计。
- 构建未来情景定义达到雄心目标所需的疫苗引入和扩大年份,作为估计2021至2030年疫苗接种长期影响的输入。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential impact of the aspirational coverage targets for IA2030, we developed an analytical framework and estimated the number of deaths averted due to an ambitious vaccination coverage scenario from 2021 to 2030 in 194 countries. METHOD: A demographic model was used to determine annual age-specific mortality estimates associated with vaccine coverage rates. For ten pathogens (Hepatitis B virus, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, Neisseria meningitidis serogroup A, Streptococcus pneumoniae, rotavirus, rubella, yellow fever), we derived single measures of country-, age-, and pathogen-specific relative risk of deaths conditional upon coverage rates, leveraging the data from 18 modeling groups as part of the Vaccine Impact Model Consortium (VIMC) for 110 countries. We used a logistic regression model to extrapolate the relative risk estimates to countries that were not modeled by VIMC. For four pathogens (diphtheria, tetanus, pertussis and tuberculosis), we used estimates from the Global Burden of Disease 2019 study and existing literature on vaccine efficacy. A future scenario defining years of vaccine introduction and scale-up needed to reach aspirational targets was developed as an input to estimate the long-term impact of vaccination taking place from 2021 to 2030. FINDINGS: Overall, an estimated 51.5 million (95 % CI: 44.0-63.2) deaths are expected to be averted due to vaccinations administered between the years 2021 and 2030. With immunization coverage projected to increase over 2021-2030 an average of 5.2 million per year (4.4-6.3) deaths will be averted annually, with 4.4 million (3.9-5.1) deaths be averted for the year 2021, gradually rising to 5.8 million (4.9-7.5) deaths averted in 2030. The largest proportion of deaths is attributed to Measles and Hepatitis B accounting for 18.8 million (17.8-20.0) and 14.0 million (11.5-16.9) of total deaths averted respectively. INTERPRETATION: The results from this global analysis demonstrate the substantial potential mortality reductions achievable if the IA2030 targets are met by 2030. Deaths caused by vaccine preventable diseases disproportionately affect LMICs in the African region.
引用
- Carter A, Msemburi W, Sim SY, et al. Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030. Vaccine. 2023. PMID: 37537094. doi:10.1016/j.vaccine.2023.07.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。